Your browser doesn't support javascript.
loading
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.
Lancet ; 380(9855): 1749-58, 2012 Nov 17.
Article in En | MEDLINE | ID: mdl-23036896

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Pyridones / Warfarin / Stroke / Hemorrhage / Anticoagulants Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Lancet Year: 2012 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Pyridones / Warfarin / Stroke / Hemorrhage / Anticoagulants Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Lancet Year: 2012 Type: Article Affiliation country: United States